Drug Approval | May 07, 2026
Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Approval strengthens the company’s growing international anti-infective portfolio
Approval strengthens the company’s growing international anti-infective portfolio
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
This is an exciting and meaningful milestone for GRIN Therapeutics
The initiative aims to encourage women and parents to seek timely medical guidance on cervical cancer prevention and HPV awareness
The device is designed for early and accurate diagnosis of obstructive airway diseases such as COPD, and Asthma
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Subscribe To Our Newsletter & Stay Updated
